Motley Crue: BMG Acquires $90M Recordings Catalogue

In a major music rights deal, German media company BMG acquired Motley Crue's recording catalog for approximately $90 million, according to Music Business Worldwide. The sale includes the band's master recordings, which span over 10 studio albums and numerous hit singles.

Founded in 1981, Motley Crue is one of the most successful and influential bands in heavy metal history. Their discography includes classics like "Shout at the Devil," "Dr. Feelgood," and "The Dirt." The band's music has been certified multi-platinum and has sold millions of copies worldwide.

Music catalog sales have gained significant attention in recent years as a lucrative investment opportunity. These assets provide a steady stream of revenue through royalties and sync licensing. According to Forbes, music rights have outperformed the S&P 500 for the past 25 years.

The sale of Motley Crue's catalog to BMG is a testament to the enduring value of music intellectual property. The deal also highlights the growing interest from investors and major labels in acquiring music catalogs.

As music rights societies like ASCAP and BMI continue to collect and distribute royalties, the ownership and control of these assets become increasingly important. Understanding the types of music rights and how they work is crucial for artists, investors, and industry professionals alike.

For more information on music rights and catalog sales, check out these resources:

Stay up to date.
Join our newsletter.

Stockholm

Sweden

All rights reserved Anotherblock © 2024

This website (the “Platform”) is managed by Anotherblock AB. By accessing this Platform and its various pages, you agree to comply with its Privacy Policy. The Platform is intended for the use of accredited investors only, and Anotherblock AB does not guarantee the accuracy or completeness of the information provided on any of its pages. Anotherblock AB does not offer investment recommendations or provide legal, tax, or financial advice. No communication should be construed as an endorsement of any investment opportunity, and there is no guarantee that any investment valuation is precise or that any investment opportunity is appropriate for any particular accredited investor.